Sign in to view content

Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up

Caesar K. Luo, MD, FASRS

Video
Published 2020

Related

Differences in Intravitreal Silicone Oil Following Multiple Bevacizumab, Ranibizumab, and Aflibercept Injections
John T. Thompson, MD
Annual Meeting Talks
2019
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Potential Safety Concerns of Bevacizumab for Retinopathy of Prematurity
Robert L. Avery, MD
Annual Meeting Talks
2016

Category: Diabetic Retinopathy

See more